The right to health is guaranteed to all individuals, without any discrimination based on gender, race, ethnicity, or socio-economic status
The PM-Ayushman Bharat Health infrastructure Mission (PM-ABHIM) has turned out to be a major laggard in the financial year 2022-23 based on the expenditure of the fund allocated to the scheme, a parliamentary committee has observed. In its 144th report tabled in the Lok Sabha on Monday, the Department Related Parliamentary Standing Committee on Health and Family Welfare highlighted that the department has been able to utilise just about 20 per cent of its budget estimates allocation. It said 2021-22 is the second year of the implementation of the PM-ABHIM scheme. "Considering that the scheme has a fixed timeline for completion, the committee is surprised that the activities under the scheme have not moved beyond nascent stages of implementation," the report said. The committee in its report stated that the scheme was allocated Rs 690.00 crore in budget estimates 2022-23, which was reduced to Rs 378.27 crore in the revised estimated 2023-24. Again out of this reduced budget, the ..
Success will help in reducing government spending for the poor battling the cost of treating non-communicable diseases
According to GT Bharat's monthly Dealtracker, the biggest deal in October was Torrent Pharma's $250 million acquisition of Curatio Healthcare
Investment activity in the health care space has not slowed down due to the Covid-19 pandemic
International patient revenues up 16% during quarter, 110% of pre-Covid average; PAT grows 29% on like-to-like basis
AltG's APEX Formula tells us that "Leveraging Fixed Assets" is the ONLY way to create Multi-Billion Dollar opportunities in the Indian Diagnostic Space.
It cites government note saying healthcare services provided by clinical establishments or authorised medical practitioners would not attract GST
About 92% of cases in India are said to be having mild disease. In only 5.8% of cases oxygen therapy is required, intensive care in only 1.7% cases
Several hospital players are on an expansion spree, as things are getting better for them after the Covid lull. Will the aggressive expansion cycle help the sector achieve sustainable growth ahead?
The Drugs Controller General of India (DCGI), on Tuesday, approved Bharat Biotech's anti-covid vaccine for emergency use. It is the first such vaccine in the country
State governments, as well as e-commerce players, are taking initiatives to launch healthcare services through drones into remote areas
KKR sold the entire 26.8% stake worth Rs 9,400 cr as part of its exit strategy
Death from chikungunya is rare but it can cause severe health issues in some people. Here are more details about the illness, its symptoms, and prevention methods
Delhi and Kerala have 3 district hospitals per district; Uttar Pradesh has two. Telangana has one hospital for five districts
While 3 cases have been reported from Kerala, one was reported in the national capital. India has now started discussions with vaccine makers to develop a monkeypox vaccine
The consortium is developing or designing a new vaccine concept that confers highly cross-reactive protection against numerous SARS-CoV-2 variants of concern
Dismal realities about health care in the National Capital Region
India will require an additional 1.3 billion square feet of healthcare space by 2030 to reach the global hospital beds-to-population average, according to CBRE. In its report 'The Evolving Indian Healthcare Ecosystem: What It Means for the Real Estate Sector', CBRE mentioned that the total number of beds available in India was 1.9 million in 2019, while the total area of healthcare space was 0.9 billion square feet. The consultant has projected that 2.9 million beds will be required by 2030 to reach the global average. The total additional area required to reach the global bed-to-population average would be 1.3 billion square feet by 2030. "India has one of the lowest bed-to-population ratios in the world, which is indicative of the infrastructure gap as well as the vast growth potential of this segment," CBRE South Asia said in a statement. The demand for quality healthcare has accelerated in tier II and III cities, it noted. Anshuman Magazine, Chairman & CEO - India, South-East
The vaccine - GEMCOVAC-19 - is the country's first homegrown mRNA Covid- 19 vaccine and is seen as a game-changer for the healthcare industry.